ULBI — Ultralife Income Statement
0.000.00%
- $174.71m
- $189.86m
- $158.64m
- 85
- 60
- 95
- 94
Annual income statement for Ultralife, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 107 | 108 | 98.3 | 132 | 159 |
Cost of Revenue | |||||
Gross Profit | 31.2 | 29.2 | 24.6 | 29.4 | 39.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 99.4 | 100 | 98.2 | 132 | 149 |
Operating Profit | 7.37 | 7.29 | 0.035 | 0.129 | 9.47 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.77 | 7.02 | -0.151 | -0.446 | 9.12 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.31 | 5.33 | -0.23 | -0.12 | 7.17 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 5.21 | 5.23 | -0.234 | -0.119 | 7.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.21 | 5.23 | -0.234 | -0.119 | 7.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.322 | 0.25 | -0.015 | 0.024 | 0.448 |